<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>"OPTIMIZING ADHERENCE TO ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV: ANALYSIS OF FACTORS AND STRATEGIES FOR IMPROVEMENT"</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Laziz N.</mods:namePart><mods:namePart type="family">Tuychiev</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Gulnara K.</mods:namePart><mods:namePart type="family">Khudaykulova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Khumoyun Mirzo</mods:namePart><mods:namePart type="family">A.Sadikov.</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>HIV remains one of the most serious global public health challenges, particularly affecting vulnerable populations, including children. Despite significant advances in antiretroviral therapy (ART) and its widespread use, adherence to treatment among HIV-infected children remains a pressing issue. Low adherence to ART can lead to reduced drug efficacy, the development of drug resistance, and a deterioration in the patient's quality of life.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-02-02</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Center for Tech and Media Research</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>